NCT05930457

Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is the study of 64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.

Conditions

• Malignant Solid Tumors

Interventions

Type	Name	Description
DRUG	2.5-3.5mCi 64Cu-FAPI-XT117	64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 2.5-3.5mCi 64Cu-FAPI-XT117 injection.
DRUG	3.5-4.5mCi 64Cu-FAPI-XT117	64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 3.5-4.5mCi 64Cu-FAPI-XT117 injection.
DRUG	4.5-5.5mCi 64Cu-FAPI-XT117	64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 4.5-5.5mCi 64Cu-FAPI-XT117 injection.

Timeline

• Start date: 2023-07-26
• Primary completion: 2023-10-31
• Completion: 2023-12-18
• First posted: 2023-07-05
• Last updated: 2023-12-26

Locations

1 site across 1 country: China